Answer:
The type of mutation responsible for changing a base in the mRNA strand, without changing the coding aminoacid or protein, is called a <u>silent</u> mutation.
Explanation:
In a silent mutation occurs the change of a nitrogenous base in one of the codons that encodes an aminoacid, without changing the aminoacid or altering the structure or function of the protein to be synthesized.
In this type of mutations the change of the base does not mean the change of the aminoacid, because some aminoacids can be coded with more than one codon. In the case of Leucine, the codons that encode it are CUU, CUC, CUG or CUA, so even if a base changes, the final protein will be the correct one.
For the other options:
- <u><em>Missense</em></u><em>: the change of the base in the DNA chain implies the change of the codon in the mRNA and of the encoded aminoacid, in that way a structural and functional alteration of the synthesized protein occurs. </em>
- <u><em>Nonsense</em></u><em>: the change in the nitrogenous base in the DNA leads to the coding of a termination codon, so that the protein is ultimately incomplete.</em>
- <u><em>Insertion</em></u><em>: in this case there is the addition of more nitrogenous bases to the DNA chain, with respect to the original one.</em>
Answer and Explanation:
The manipulation of the gene is called genetic engineering. In genetic engineering, fragments of genes are cloned by leading the genes into the host cell. The advantage of using a prokaryotic host system in genetic engineering is that bacterial cells are used to produce commercially significant products. For example, human growth hormone helps to treat dwarfism, and human insulin production, which is used to treat diabetes. The bacterium P.putida is created by genetic engineering, which is used to break down petroleum products. Genetic engineering also carries some potential risks, such as transferring the selected gene into another speice, benefit one species can harm another speice. Therefore genetic engineering must be used in limit in prokaryotes. These limitations are also addressable in single-cell eukaryotic systems. Biologics-based therapeutic medicines such as a vaccine, gene therapies, and cell therapies known as bioproduction are produced. Medicines are so complex that they can only be formed in a living system. Biopharmaceuticals, value-added food, fuels, chemicals, antibiotics, and many other products are produced by bioproduction.
These are the two domains Archaea & Bacteria.
Coordinates muscles controlling breathing ..
Hope it helps.
